Press release
Colorectal Cancer Screening Market to Reach USD 32.8 Billion by 2034
Colorectal Cancer Screening Market to Reach USD 32.8 Billion by 2034
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/47963
Key Takeaways
• Market Size 2024: USD 18.9 Billion
• Forecast 2034: USD 32.8 Billion
• CAGR (2025-2034): 5.7%
• Major Screening Tests: Fecal Occult Blood Test (FOBT), Fecal Immunochemical Test (FIT), Stool DNA Test, Colonoscopy, Sigmoidoscopy
• Key Drivers: Rising Cancer Awareness, Aging Population, AI-based Imaging, and Non-invasive Diagnostic Advances
• Top Regions: North America, Europe, Asia Pacific
• Leading Companies: Exact Sciences Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Eiken Chemical Co. Ltd., Olympus Corporation, Epigenomics AG, Quest Diagnostics, Bio-Rad Laboratories, Medtronic
Market Story
The colorectal cancer (CRC) screening market is witnessing strong growth as healthcare systems worldwide focus on early detection and preventive oncology. Colorectal cancer remains the third most common cancer globally, yet highly treatable if detected early. The integration of AI-powered colonoscopy systems, genetic biomarker testing, and home-based screening kits is transforming accessibility and precision in diagnosis.
Governments and healthcare providers are implementing national screening programs to reduce cancer mortality rates, while technological innovations are improving test accuracy and patient compliance. The rise of non-invasive at-home tests like stool DNA kits has significantly boosted participation, particularly in developed countries.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/47963/colorectal-cancer-screening-market
Segmentation Overview
• By Test Type:
Fecal Occult Blood Test (FOBT), Fecal Immunochemical Test (FIT), Stool DNA Test, Colonoscopy, Sigmoidoscopy, Others
• By Age Group:
Below 50 Years, 50-75 Years, Above 75 Years
• By End User:
Hospitals, Diagnostic Laboratories, Home Care Settings, Ambulatory Surgical Centers
• By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Recent Developments
• Exact Sciences Corporation: Expanded its Cologuard® stool DNA test for average-risk adults, with enhanced AI analytics for mutation detection.
• Abbott Laboratories: Launched high-sensitivity FIT test systems for large-scale population screening programs.
• Siemens Healthineers: Integrated AI algorithms into colonoscopy imaging for real-time polyp detection.
• Olympus Corporation: Introduced 4K endoscopic systems enhancing visualization during colorectal procedures.
• Epigenomics AG: Advanced its Epi proColon® blood-based test targeting improved early detection accuracy.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=47963
Expert Insight
"Colorectal cancer screening is entering an era of digital precision. With AI, molecular biomarkers, and patient-friendly testing, screening programs are evolving from detection tools into predictive, life-saving systems," said Anurag Tiwari, Senior Healthcare Analyst at Exactitude Consultancy.
Market Drivers
1. Rising Global Incidence of Colorectal Cancer: Increasing cases among both aging and younger populations emphasize the need for mass screening.
2. Shift Toward Non-Invasive Testing: Home-based kits and liquid biopsy solutions improve patient compliance.
3. Government Screening Initiatives: National health programs promote widespread adoption across public and private healthcare systems.
4. Technological Innovations: AI-driven imaging, high-resolution endoscopy, and biomarker-based tests enhance diagnostic precision.
5. Growing Awareness & Insurance Support: Preventive healthcare policies and reimbursement schemes boost accessibility.
Forecast & Regional Insights
North America dominates the global colorectal cancer screening market, driven by high awareness, advanced healthcare infrastructure, and established reimbursement policies. Europe follows, with strong implementation of public screening programs. Meanwhile, Asia Pacific is expected to experience the fastest growth due to increasing healthcare spending, rising cancer incidence, and expanding adoption of affordable diagnostics in India, China, and Japan.
By 2034, technological convergence-AI imaging, molecular testing, and remote patient monitoring-will redefine colorectal screening as a data-driven, preventive, and personalized healthcare discipline.
Conclusion
The Colorectal Cancer Screening Market represents a critical component of global oncology prevention strategies. With ongoing innovation in AI diagnostics, at-home testing, and personalized medicine, the market is well-positioned to reduce cancer mortality rates and improve long-term patient outcomes worldwide.
This report is also available in the following languages : Japanese (大腸がん検診市場), Korean (대장암 검진 시장), Chinese (结直肠癌筛查市场), French (Marché du dépistage du cancer colorectal), German (Markt für Darmkrebsvorsorge), and Italian (Mercato dello screening del cancro colorettale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/47963
Our More Reports:
Vaccine Delivery Devices Market
https://exactitudeconsultancy.com/reports/73477/vaccine-delivery-devices-market
Amyloidosis Clinical Market
https://exactitudeconsultancy.com/reports/73634/amyloidosis-clinical-market
Women's Digital Health Fundamental Analysis Market
https://exactitudeconsultancy.com/reports/73703/women-s-digital-health-fundamental-analysis-market
Clinical Trial Software Market
https://exactitudeconsultancy.com/reports/73711/clinical-trial-software-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Screening Market to Reach USD 32.8 Billion by 2034 here
News-ID: 4262011 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Colorectal
Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685
This latest report researches the…
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and…
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @
https://goo.gl/1HQ4Fn .
Report Description:
Pharmaceutical guide Colorectal Cancer - Pipeline Review H1…
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die…
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in…
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which…
